A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.

By B. Iung, G. Baron, E. Butchart, F. Delahaye, C. Gohlke-Bärwolf, O. Levang, P. Tornos, J. Vanoverschelde, F. Vermeer, E. Boersma and 2 more. European Heart Journal, 2003

3,474 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology

View Paper: https://www.semanticscholar.org/paper/dbb225d6229091c4038037f842fd23ee45094a46

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Epidemiology

Citations in the corpus

Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. (2017, background): “Significant acquired PR is rare, occurring in <1% of patients, and is present in adults with pathologies such as rheumatic heart disease, endocarditis, carcinoid valve disease, or pergolide-induced disease.(253,254) Rarely blunt chest trauma can lead to leaflet disruption and prolapse.”
Epidemiology of valvular heart disease in the adult (2011, methodology): “Distribution and etiologies The Euro Heart Survey was specifically designed to study the management of patients with valvular heart disease and prospectively included 5,001 patients from 92 centers in 25 European countries”
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2012, positive): “Congenital abnormalities, mainly bicuspid morphology, are the second most frequent finding.(1,12,48) The analysis of the mechanism of AR influences patient management, particularly when valve repair is considered.”
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? (2005, methodology): “Details on inclusion and data collection have been previously described.(2) Isolated AS was defined by a maximum aortic velocity as assessed by Doppler echocardiography 2.”
Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. (2006, background): “However, almost one-third f patients with severe valvular lesions who could benefit ost from intervention are declined for operative treatment ecause of end-stage disease, advanced age, and multiple omorbidities with subsequent short life expectancy (1).”
Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (2006, background): “Another important aspect of contemporary VHD is the growing proportion of previously-operated patients who present with further problems [1].”
Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. (2012, background): “First, the decrease in rheumatic heart disease and the increase in degenerative heart diseases have led to an increase in patients’ age and frequency of comorbidities [2, 3].”
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. (2009, neutral): “However, it still accounts for 10% of left-sided valve diseases in Europe and it remains frequent in developing countries.(42,43) The main mechanism of rheumatic MS is commissural fusion.”